Wen-Hao Xu (Wenhao Xu)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Radical Prostatectomy

Immune Response

Top Venues

Journal of cellular biochemistry

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Hao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wang-Rui Liu, Kun Chang, Hai-Liang Zhang, Dingwei Ye
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5 (1) (2024)
Wen-Hao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wang-Rui Liu, Kun Chang, Hai-Liang Zhang, Dingwei Ye
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5 (1) (2024)
Wen-Hao Xu, Jianfeng Yang, Shiqi Ye, Wangrui Liu, Jiahe Lu, Aihetaimujiang Anwaier, Hai-Liang Zhang, Dingwei Ye
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy 16 (3) (2023)
Wen-Hao Xu, Jiahe Lu, Wang-Rui Liu, Aihetaimujiang Anwaier, Yuhao Wu, Xi Tian, Jia-Qi Su, Yuan-Yuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei Ye
Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma. Journal for immunotherapy of cancer 11 (12) (2023)
Wen-Hao Xu, Jianfeng Yang, Shiqi Ye, Wangrui Liu, Jiahe Lu, Aihetaimujiang Anwaier, Hai-Liang Zhang, Dingwei Ye
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy 16 (3) (2023)
Wen-Hao Xu, Jianfeng Yang, Shiqi Ye, Wangrui Liu, Jiahe Lu, Aihetaimujiang Anwaier, Hai-Liang Zhang, Dingwei Ye
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy (2023)
Wenkai Zhu, Fangning Wan, Wen-Hao Xu, Zheng Liu, Junjie Wang, Hena Zhang, Shenglin Huang, Dingwei Ye
Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression. Clinical and translational medicine 12 (9) (2022)
Wen-Hao Xu, Aihetaimujiang Anwaier, Wang-Rui Liu, Xi Tian, Yuanyuan Qu, Jianyuan Zhao, Hailiang Zhang, Dingwei Ye
Adenylate cyclase-activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer. Clinical and translational medicine 11 (10) (2022)
Jia-Qi Su, Xi Tian, Wen-Hao Xu, Aihetaimujiang Anwaier, Shi-Qi Ye, Shu-Xuan Zhu, Yue Wang, Jun Gu, Guo-Hai Shi, Yuan-Yuan Qu, Hai-Liang Zhang, Ding-Wei Ye
The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma. Cancers 14 (20) (2022)
Xi Tian, Yue Wang, Wen-Hao Xu, Haidan Tang, Shuxuan Zhu, Aihetaimujiang Anwaier, Wang-Rui Liu, Wenfeng Wang, Wenkai Zhu, Jiaqi Su, Yuanyuan Qu, Hailiang Zhang, Ding-Wei Ye
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response. International journal of cancer 152 (1) (2022)
Wen-Hao Xu, Yue Xu, Xi Tian, Aihetaimujiang Anwaier, Wang-Rui Liu, Jun Wang, Wen-Kai Zhu, Da-Long Cao, Hong-Kai Wang, Guo-Hai Shi, Yuan-Yuan Qu, Hai-Liang Zhang, Ding-Wei Ye
Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma. Journal of cellular and molecular medicine 24 (16) (2020)
Jie Wu, Yu-Chen Wang, Wen-Hao Xu, Wen-Jie Luo, Fang-Ning Wan, Hai-Liang Zhang, Ding-Wei Ye, Yuan-Yuan Qu, Yi-Ping Zhu
High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma. OncoTargets and therapy 13 (2020)
Wen-Hao Xu, Jun Wang, Hao-Yue Sheng, Yuan-Yuan Qu, Hong-Kai Wang, Yu Zhu, Guo-Hai Shi, Hai-Liang Zhang, Ding-Wei Ye
Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer. Journal of cellular biochemistry 121 (5-6) (2019)
Yue Xu, Wei Han, Wen-Hao Xu, Yun Wang, Xiao-Long Yang, Hui-Ling Nie, Jin Yao, Guo-Liang Shen, Xiao-Feng Zhang
Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma. Journal of cellular biochemistry 120 (11) (2019)
Wen-Kai Zhu, Wen-Hao Xu, Jun Wang, Yong-Qiang Huang, Mierxiati Abudurexiti, Yuan-Yuan Qu, Yi-Ping Zhu, Hai-Liang Zhang, Ding-Wei Ye
Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients. Journal of cellular biochemistry 121 (2) (2019)